
Preclinical imaging
Expertise in the use of PET and SPECT imaging techniques to understand biological processes at the cellular and molecular level. The techniques ae also used to study disease processes and monitor the effects of new therapies
Showing 1281 - 1300 of 1965 results
Expertise in the use of PET and SPECT imaging techniques to understand biological processes at the cellular and molecular level. The techniques ae also used to study disease processes and monitor the effects of new therapies
Technical information on instruments, facilities, and access for users. The Centre is one of three research infrastructure facilities at ANSTO supported by NCRIS.
Dr Katie Sizeland, a Postdoctoral Fellow on the Small Angle X-ray Scattering beamline at the Australian Synchrotron, has been chosen for the Homeward Bound STEMM leadership program
Two Australian scientists have been appointed to assist with the development of a $500 million-dollar synchrotron facility in Mexico, the first and largest project of its kind.
Three ANSTO scientists are contributing to two recently awarded Australian Research Council Discovery Project grants.
ANSTO scientists are participating investigators in three new ARC Industrial Transformation Training Centres, recently announced by the Government.
Polarised neutron scattering on Sika instrument
ANSTO has recently concluded up a successful cross-cultural nuclear science education project between Australia and Japan.
Australian researchers and clinicians have recently returned from Japan where they investigated the use of advanced radiation therapy for cancer using heavy ions at particle therapy facilities on a study tour .
Professor Peter Lay from the University of Sydney has been awarded the Australian Synchrotron Lifetime Contribution Award by ANSTO, the Australian Nuclear Science and Technology Organisation.
A collaborative group including Monash has produced an ultra-thin and ultra-flexible organic solar cell for advanced wearable devices.
ANSTO research focuses on an advanced form of cancer treatment under consideration in Australia.